HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Acquires $18,739.90 in Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank acquired 670 shares of the business’s stock in a transaction dated Tuesday, July 26th. The shares were bought at an average price of $27.97 per share, for a total transaction of $18,739.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

HCA Healthcare Stock Down 0.0 %

Shares of HCA opened at $342.25 on Friday. The stock has a 50 day moving average price of $324.53 and a 200 day moving average price of $341.56. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company earned $5.90 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.84%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $31,000. Tidemark LLC purchased a new position in HCA Healthcare in the fourth quarter worth approximately $36,000. Legacy Investment Solutions LLC purchased a new stake in HCA Healthcare in the third quarter valued at $39,000. Activest Wealth Management grew its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. raised its holdings in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on HCA shares. Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.